|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/475 | |||
| A61K 31/519 | |||
| A61K 38/18 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 39/395 | |||
| A61K 31/4745 | |||
| A61K 31/513 | |||
| A61K 31/555 | |||
| A61K 31/704 | |||
| A61K 31/7048 | |||
| A61K 33/24 | |||
| A61K 38/17 | |||
| C07K 19/00 | |||
| C07K 14/71 |
| (11) | Patento numeris | 2640377 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11784918.2 |
| Europos patento paraiškos padavimo data | 2011-11-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/060666 |
| Data | 2011-11-14 |
| (87) | Numeris | WO 2012/068032 |
| Data | 2012-05-24 |
| (30) | Numeris | Data | Šalis |
| 413940 P | 2010-11-15 | US | |
| 421462 P | 2010-12-09 | US |
| (72) |
LONG, Li, US
BRENNAN, Thomas, US
|
| (73) |
Five Prime Therapeutics, Inc.,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES |
| FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES |